Brief: Ascentage Pharma Group International Announces Acquisition Of Shares By Directors
03/04/2024 16:08
April 3 (Reuters) - Ascentage Pharma Group International
6855.HK :
* ACQUISITION OF SHARES BY DIRECTORS
* ON APRIL 2, NON-EXECUTIVE DIRECTOR ACQUIRED 130,000
ORDINARY
SHARES OF CO ON-MARKET FOR HK$2.4 MILLION
* ON APRIL 3, EXECUTIVE DIRECTOR & CHAIRMAN ACQUIRED 100,000
SHARES OF CO ON-MARKET FOR HK$1.8 MILLION
Further company coverage: 6855.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ascentage Pharma International
See all newsBrief: Ascentage Pharma Group Says Lisaftoclax Granted Breakthrough Therapy Designation In China
China's Ascentage Pharma climbs as chairman buys shares on market
Brief: Ascentage Pharma Group International's Chairman Buys 38,630 Shares
Brief: Ascentage Pharma Group International Posts H1 Net Loss Attributable RMB816.7 Million
China's Ascentage Pharma H1 revenue rises 29% on Lisaftoclax ramp-up